Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis.

Zeerleder, Sacha; Caliezi, Christoph; van Mierlo, Gerard; Eerenberg-Belmer, Anke; Sulzer, Irmela; Hack, C Erik; Wuillemin, Walter A

Zeerleder, Sacha; Caliezi, Christoph; van Mierlo, Gerard; Eerenberg-Belmer, Anke; Sulzer, Irmela; Hack, C Erik; Wuillemin, Walter A.

Affiliation

Zeerleder S; Central Hematology Laboratory, Inselspital, Bern, Switzerland.

Clin Diagn Lab Immunol ; 10(4): 529-35, 2003 Jul.

Article in En | MEDLINE | ID: mdl-12853381

Subject(s)

Neutrophils/drug effects; Sepsis/drug therapy; Serpins/therapeutic use; Adult; Aged; Biomarkers; Complement Activation/drug effects; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Cytokines/blood; Female; Humans; Interleukin-8/metabolism; Lactoferrin/blood; Leukocyte Elastase/blood; Male; Middle Aged; Multiple Organ Failure/blood; Multiple Organ Failure/etiology; Multiple Organ Failure/physiopathology; Neutrophils/metabolism; Sepsis/blood; Sepsis/complications; Serpins/pharmacology; Shock, Septic/blood; Shock, Septic/drug therapy; alpha 1-Antitrypsin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serpins / Sepsis / Neutrophils Type of study: Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Diagn Lab Immunol Journal subject: ALERGIA E IMUNOLOGIA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 2003 Document type: Article Affiliation country: Switzerland Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google